NDAOTICSUSPENSION/DROPS
Approved
May 1975
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
3/8 — Basic
CASPORYN HC (neomycin and polymyxin b sulfates and hydrocortisone otic) by R-Pharm US is corticosteroid hormone receptor agonists [moa]. First approved in 1975.
Drug data last refreshed 38m ago · AI intelligence enriched 3w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
CASPORYN HC is a fixed-combination otic suspension containing two aminoglycoside antibiotics (neomycin and polymyxin B sulfates) plus hydrocortisone, a corticosteroid. It treats bacterial ear infections and associated inflammation of the external ear canal. The corticosteroid component reduces inflammation while the antibiotics provide broad-spectrum bacterial coverage.
LOE Approaching
Product is in late-stage lifecycle with moderate competitive pressure (30/100), indicating a mature market with limited growth opportunities and potential team restructuring ahead.
Mechanism of Action
Corticosteroid Hormone Receptor Agonists
Pharmacologic Class:
Corticosteroid
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Working on CASPORYN HC offers limited career growth given its LOE-approaching lifecycle and zero linked job openings. This role is best suited for professionals seeking stable, maintenance-focused work on an established product with predictable market dynamics rather than launch or innovation opportunities.
Brand ManagerField Sales Representative
Worked on CASPORYN HC at R-Pharm US? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.